Quality of Life in a Prospective, Multicenter Phase 2 Trial of Neoadjuvant Full-Dose Gemcitabine, Oxaliplatin, and Radiation in Patients With Resectable or Borderline Resectable Pancreatic Adenocarcinoma

✍ Scribed by Serrano, Pablo E.; Herman, Joseph M.; Griffith, Kent A.; Zalupski, Mark M.; Kim, Edward J.; Bekaii-Saab, Tanios S.; Ben-Josef, Edgar; Dawson, Laura A.; Ringash, Jolie; Wei, Alice C.

• Book ID: 126997521
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 723 KB
• Volume: 90
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2014.05.053